LOCALLY ADVANCED RECTAL CANCER (LARC)
Clinical trials for LOCALLY ADVANCED RECTAL CANCER (LARC) explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED RECTAL CANCER (LARC) trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED RECTAL CANCER (LARC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Drug attack tested to shrink rectal tumors before surgery
Disease control OngoingThis study is testing whether adding two newer types of drugs (a PCSK9 inhibitor and a PD-1 inhibitor) to standard pre-surgery chemotherapy and radiation can better shrink tumors in people with a specific type of locally advanced rectal cancer. It will enroll about 30 patients to…
Matched conditions: LOCALLY ADVANCED RECTAL CANCER (LARC)
Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New combo therapy aims to shrink rectal tumors without radiation
Disease control OngoingThis study is testing a new treatment approach for advanced rectal cancer that avoids radiation. It combines two chemotherapy drugs with an immunotherapy drug before surgery, aiming to shrink the tumor effectively while reducing side effects that can harm long-term anal function.…
Matched conditions: LOCALLY ADVANCED RECTAL CANCER (LARC)
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC